These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 1522554

  • 1. Evaluation of L-asparaginase: polyethylene glycol conjugate versus native L-asparaginase combined with chemotherapy. A randomized double-blind study in canine lymphoma.
    MacEwen EG, Rosenthal RC, Fox LE, Loar AS, Kurzman ID.
    J Vet Intern Med; 1992; 6(4):230-4. PubMed ID: 1522554
    [Abstract] [Full Text] [Related]

  • 2. Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma.
    Teske E, Rutteman GR, van Heerde P, Misdorp W.
    Eur J Cancer; 1990; 26(8):891-5. PubMed ID: 2145933
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT, Mauldin GE, Mauldin GN, Brodsky EM, Post GS.
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [Abstract] [Full Text] [Related]

  • 5. An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia.
    Ettinger LJ, Kurtzberg J, Voûte PA, Jürgens H, Halpern SL.
    Cancer; 1995 Mar 01; 75(5):1176-81. PubMed ID: 7850718
    [Abstract] [Full Text] [Related]

  • 6. Treatment of canine lymphoma with COPLA/LVP.
    Boyce KL, Kitchell BE.
    J Am Anim Hosp Assoc; 2000 Mar 01; 36(5):395-403. PubMed ID: 10997514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia].
    Jürgens H, Schwamborn D, Körholz D, Wahn V, Göbel U.
    Klin Padiatr; 1988 Mar 01; 200(3):184-9. PubMed ID: 3210651
    [Abstract] [Full Text] [Related]

  • 9. Polyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).
    Kurtzberg J, Asselin B, Bernstein M, Buchanan GR, Pollock BH, Camitta BM.
    J Pediatr Hematol Oncol; 2011 Dec 01; 33(8):610-6. PubMed ID: 22042277
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma.
    Myers NC, Moore AS, Rand WM, Gliatto J, Cotter SM.
    J Vet Intern Med; 1997 Dec 01; 11(6):333-9. PubMed ID: 9470157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF, Thamm DH, Vail DM.
    J Vet Intern Med; 2007 Dec 01; 21(1):127-32. PubMed ID: 17338160
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF, Hafeman SD, Vail DM, Thamm DH.
    J Vet Intern Med; 2009 Dec 01; 23(5):1058-63. PubMed ID: 19678892
    [Abstract] [Full Text] [Related]

  • 14. Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Abshire TC, Pollock BH, Billett AL, Bradley P, Buchanan GR.
    Blood; 2000 Sep 01; 96(5):1709-15. PubMed ID: 10961868
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH.
    J Vet Intern Med; 2024 Sep 01; 38(4):2282-2292. PubMed ID: 38961691
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
    Jeglum KA, Young KM, Barnsley K, Whereat A.
    Cancer; 1988 May 15; 61(10):2042-50. PubMed ID: 3359402
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma.
    Moore AS, Cotter SM, Rand WM, Wood CA, Williams LE, London CA, Frimberger AE, L'Heureux DA.
    J Vet Intern Med; 2001 May 15; 15(4):348-54. PubMed ID: 11467592
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
    Simon D, Nolte I, Eberle N, Abbrederis N, Killich M, Hirschberger J.
    J Vet Intern Med; 2006 May 15; 20(4):948-54. PubMed ID: 16955821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.